Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Change in Taxes (2010 - 2025)

Grifols' (GIFLF) quarterly Change in Taxes came in at -$196.7 million in Q4 2025, down 4.6% on a YoY basis from -$206.2 million in Q4 2024, and down 4.6% quarter-over-quarter from -$188.1 million in Q4 2024.

Analysis

Grifols (GIFLF) Change in Taxes (2010 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Change in Taxes for 11 consecutive years, with -$196.7 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Change in Taxes fell 4.6% year-over-year to -$196.7 million; the trailing twelve-month figure through Dec 2025 stood at -$756.3 million (changed 0.25% YoY), and the FY2025 full-year result was -$190.9 million, down 1.52% from the prior year.
  • Change in Taxes fell to -$196.7 million in Q4 2025 per GIFLF's latest filing, from -$188.1 million in the prior quarter.
  • Across five years, Change in Taxes topped out at -$171.1 million in Q4 2023 and bottomed at -$200.4 million in Q4 2022.
  • Historically, Change in Taxes has averaged -$189.1 million across 4 years, with a median of -$192.4 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Change in Taxes advanced 14.64% in 2023, then declined 9.94% in 2024.
  • Over 4 years, Change in Taxes stood at -$200.4 million in 2022, then rose by 14.64% to -$171.1 million in 2023, then declined by 9.94% to -$188.1 million in 2024, then dropped by 4.6% to -$196.7 million in 2025.
  • According to Business Quant data, Change in Taxes over the past three periods registered -$196.7 million, -$188.1 million, and -$171.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn -131.00 Mn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 171.00 Mn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn -
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn -
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn 13.80 Mn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn -10.18 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn -196.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -196.72 Mn
Dec 31, 2024 -188.07 Mn
Dec 31, 2023 -171.07 Mn
Dec 31, 2022 -200.41 Mn
Sep 30, 2016 -194.84 Mn
Sep 30, 2015 81.12 Mn
Sep 30, 2014 45.52 Mn
Jun 30, 2014 -16.34 Mn
Mar 31, 2014 16.35 Mn
Sep 30, 2013 59.52 Mn
Jun 30, 2013 75.51 Mn
Mar 31, 2013 5.74 Mn
Dec 31, 2012 -135.34 Mn
Sep 30, 2012 27.44 Mn
Jun 30, 2012 31.30 Mn
Mar 31, 2012 -3.27 Mn
Dec 31, 2011 10.87 Mn
Sep 30, 2011 13.48 Mn
Dec 31, 2010 -15.59 Mn
Sep 30, 2010 -3.12 Mn